Data compiled by Redley Lamar · ChainSifter Intelligence
5Suppliers
4Customers
1Debt Items
20Related Chains
Source-Backed Evidence Depth
Nymox Pharmaceutical Corporation (NYMXF) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
2Distinct source URLs
6High confidence
0.808Average confidence
2026-10-29Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Nymox Pharmaceutical Corporation Suppliers
Ticker
Name
Confidence
Evidence
RECORDATI-IRELAND-LTD
RECORDATI-IRELAND-LTD
90%
4(t)* License and Collaboration Agreement between Nymox Pharmaceutical Corporation and Recordati Ireland Ltd. dated December 16, 2010.
MASSACHUSETTS-GENERAL-HOSPITAL-CORPORATION
MASSACHUSETTS-GENERAL-HOSPITAL-CORPORATION
80%
4(c) Research and License Agreement between the Massachusetts General Hospital Corporation and the Corporation
RHODE-ISLAND-HOSPITAL-CORPORATION
RHODE-ISLAND-HOSPITAL-CORPORATION
80%
4(i) Research and License Agreement between the Rhode Island Hospital Corporation and the Corporation dated May 14, 1999
unoassay developers such as OraSure Technologies Inc. and Abraxis LLC, and diagnostic system manufacturers such as Roche Diagnostics, Abbott and Siemens Medical Solutions. NicAlert™ and TobacAlert™ a…
Reciprocal relationship from LLY graph: Reciprocal relationship from NYMXF graph: Reciprocal relationship from LLY graph: Reciprocal relationship from NYMXF graph: unoassay developers such as OraSure…
Nymox Pharmaceutical Corporation Customers
Ticker
Name
Confidence
Evidence
JASPAS-INVESTMENTS-LIMITED
JASPAS-INVESTMENTS-LIMITED
90%
4(e) Common Stock Purchase Agreement between Nymox Pharmaceutical Corporation and Jaspas Investments Limited dated November 1, 1999
LORROS-GREYSE-INVESTMENTS-LTD
LORROS-GREYSE-INVESTMENTS-LTD
90%
4(s) Common Stock Private Purchase Agreement between Nymox Pharmaceutical Corporation and Lorros-Greyse Investments, Ltd. dated November 1, 2010.
and will continue through full implementation in 2014 and beyond. The new law is expected to expand access to health care to more than 32 million Americans by the end of the decade. These changes may…
Reciprocal relationship from LLY graph: Reciprocal relationship from NYMXF graph: and will continue through full implementation in 2014 and beyond. The new law is expected to expand access to health …
Nymox Pharmaceutical Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
NYMXF-DEBT
Debt stack $3.3M
90%
Market cache reports total debt of $3.3M.
Nymox Pharmaceutical Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Nymox Pharmaceutical Corporation.
Nymox Pharmaceutical Corporation Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Nymox Pharmaceutical Corporation.
